To overcome this limitation, future studies are needed to examine human saliva samples to clarify the relationship between salivary flotillin-1 levels and brain Aβ burden in patients with Alzheimer’s disease. This evidence concerns the gene FLOT1 and early-onset autosomal dominant Alzheimer disease.